As of 2024-10-13, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 48.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.35 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -30.5%.
The range of the Relative Valuation is 35.27 - 71.49 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.6x - 53.0x | 43.3x |
| Forward P/E multiples | 31.8x - 41.3x | 35.6x |
| Fair Price | 35.27 - 71.49 | 48.92 |
| Upside | -49.9% - 1.6% | -30.5% |
| Date | P/E |
| 2024-10-11 | 52.19 |
| 2024-10-10 | 51.82 |
| 2024-10-09 | 51.78 |
| 2024-10-08 | 50.96 |
| 2024-10-07 | 51.16 |
| 2024-10-04 | 51.57 |
| 2024-10-03 | 50.57 |
| 2024-10-02 | 51.68 |
| 2024-10-01 | 52.01 |
| 2024-09-30 | 52.15 |
| 2024-09-27 | 52.36 |
| 2024-09-26 | 52.11 |
| 2024-09-25 | 51.21 |
| 2024-09-24 | 51.55 |
| 2024-09-23 | 51.29 |
| 2024-09-20 | 52.44 |
| 2024-09-19 | 52.98 |
| 2024-09-18 | 52.78 |
| 2024-09-17 | 52.34 |
| 2024-09-16 | 51.83 |
| 2024-09-13 | 62.99 |
| 2024-09-12 | 62.60 |
| 2024-09-11 | 62.90 |
| 2024-09-10 | 62.95 |
| 2024-09-09 | 62.56 |
| 2024-09-06 | 62.38 |
| 2024-09-05 | 63.15 |
| 2024-09-04 | 66.67 |
| 2024-09-03 | 67.95 |
| 2024-08-30 | 67.67 |
| 2024-08-29 | 67.79 |
| 2024-08-28 | 67.01 |
| 2024-08-27 | 67.11 |
| 2024-08-26 | 66.76 |
| 2024-08-23 | 66.79 |
| 2024-08-22 | 66.79 |
| 2024-08-21 | 68.68 |
| 2024-08-20 | 69.62 |
| 2024-08-19 | 68.82 |
| 2024-08-16 | 66.42 |
| 2024-08-15 | 66.16 |
| 2024-08-14 | 66.48 |
| 2024-08-13 | 67.50 |
| 2024-08-12 | 66.05 |
| 2024-08-09 | 65.76 |
| 2024-08-08 | 65.21 |
| 2024-08-07 | 64.03 |
| 2024-08-06 | 64.45 |
| 2024-08-05 | 59.70 |
| 2024-08-02 | 62.47 |